Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Viela Bio Shares Spike Higher

Toward the end of trading Monday, the Dow traded up 1.10% to 30,311.21 while the NASDAQ rose 2.58% to 13,408.42. The S&P also rose, gaining 1.80% to 3,781.16.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 26,188,080 cases with around 441,330 deaths. India confirmed a total of at least 10,757,610 confirmed cases and 154,390 deaths, while Brazil reported over 9,204,730 COVID-19 cases with 224,500 deaths. In total, there were at least 103,034,950 cases of COVID-19 worldwide with over 2,229,560 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors


Information technology shares rose 2.8% on Monday. Meanwhile, top gainers in the sector included Alithya Group Inc. ALYA, up 33%, and Agora, Inc. API, up 29%.


In trading on Monday, consumer staples shares rose by just 0.5%.


Top Headline

Thermo Fisher Scientific Inc. TMO reported better-than-expected results for its fourth quarter.

Thermo Fisher Scientific reported quarterly earnings of $7.09 per share, missing analysts’ expectations of $6.56 per share. The company posted revenue of $10.55 billion, versus estimates of $9.58 billion.

 


Equities Trading UP


Dynavax Technologies Corporation DVAX shares shot up 71% to $10.79 after the company said it would launch a Phase 2/3 trial of its COVID-19 vaccine candidate. HC Wainwright & Co. maintained Dynavax Technologies with a Buy and raised the price target from $14 to $15.


Shares of Viela Bio, Inc. VIE got a boost, shooting 53% to $52.92 after the company agreed to be acquired by Horizon Therapeutics for $53 per share in cash.


Tuscan Holdings Corp. THCB shares were also up, gaining 52% to $23.76 following news that the company and Microvast, Inc have entered into a definitive merger agreement.

Check out these big movers of the day


Equities Trading DOWN

Concert Pharmaceuticals, Inc. CNCE shares tumbled 32% to $7.10 after the company announced that its CTP-692 Phase 2 trial did not achieve its primary endpoint assessing positive and negative syndrome scale total score at 12 weeks.

Shares of Bed Bath & Beyond Inc. BBBY were down 15% to $30.17, selling off following last week's surge, which was driven by high retail investor interest and speculative trading. KeyBanc also downgraded Bed Bath & Beyond from Sector Weight to Underweight and announced a $24 price target.

Matinas BioPharma Holdings, Inc MTNB was down, falling 33% to $0.9838 said the primary endpoint did not meet statistical significance over Vascepa in its ENHANCE-IT study of LYPDISO.


Commodities


In commodity news, oil traded up 2.4% to $53.43, while gold traded up 0.7% to $1,863.10.


Silver traded up 8% Monday to $29.065 while copper rose 0.2% to $3.5615.


Euro zone

European shares closed higher today. The eurozone’s STOXX 600 gained 1.24%, the Spanish Ibex Index rose 0.52% and the German DAX 30 gained 1.41%. Meanwhile, the French CAC 40 climbed 1.16%, London’s FTSE 100 rose 0.92% and Italy’s FTSE MIB surged 1.17%.

The Eurozone unemployment rate remained at 8.3% in December, while manufacturing PMI climbed to 54.8 in January from a preliminary reading of 54.7. UK manufacturing PMI rose to 54.1 in January from a preliminary reading of 52.9, while retail sales in Germany dropped 9.6% in December.


Economics

The IHS Markit manufacturing PMI rose to 59.2 in January from preliminary estimate of 59.1.


The ISM manufacturing PMI declined to 58.7 in January from 60.5 in December.


US construction spending rose 1% for December.


Federal Reserve Bank of Boston President Eric Rosengren will speak at 3:10 p.m. ET.

Check out the full economic calendar here

Posted In: Mid-Afternoon Market UpdateEarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarkets

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.